Tag: Natco Pharma
NATCO launches Epilepsy Tablets in India
Natco Pharma announced the launch of Brivaracetam tablets under brand BRECITA in India.
Brivaracetam is indicated for the treatment...
USFDA approves Pomalidomide capsules for Natco
Natco Pharma announced that its marketing partner, Breckenridge Pharmaceutical, has received final approval for its Abbreviated New Drug Application (ANDA) for Pomalidomide...
Natco Pharma to launch 8-10 new drugs in India yearly
Hyderabad: Natco Pharma aims to launch around 10 new products every year in the Indian market, the city-based drug maker said on Thursday. "Our strategy remains...
Natco Pharma gets EIR from USFDA
Natco Pharma Limited has received Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for Kothur's formulation facility.
Natco Pharma completes USFDA inspection
The formulation facility of Natco Pharma in Kothur village, near Hyderabad, has received a single observation at the end of a pre-approval...